Ophthalmic Plastic and Reconstructive Surgery · 2016 · 45 citations · 4 references
MedicineEndocrinologyOphthalmologyOcular DiseaseOcular PharmacologyOphthalmic SurgeryAntithyroid DrugsEye DiseaseOrbital DiseaseOrbital InflammationThyroid DisordersThyroid Eye DiseaseClinical Activity ScoringDurable Clinical ResponseGraves' Disease TreatmentModerate Thyroid Eye DiseaseOrbital Fat DisordersOrbital Fat InflammationSevere Thyroid Eye DiseaseThyroid Eye Disease Decompression
Tocilizumab, in a preliminary study, was reported to be an effective therapy for moderate to severe thyroid eye disease. The authors describe the clinical response of 2 severe thyroid eye disease cases refractory to intravenous steroids and orbital decompression. Both patients demonstrated improved clinical activity scores with minimal side effects after tocilizumab therapy. In addition, post tocilizumab orbital fat biopsies demonstrated benign adipose tissue without evidence of inflammatory cells.
4
Long-Term Effects of Tocilizumab Therapy for Refractory Uveitis-Related Macular Edema
Marina Mesquida, Blanca Molins, Víctor Llorenç et al. · Ophthalmology · 2014 · 101 citations
Donata Urbaniak‐Kujda, Anna Bohdanowicz-Pawlak, Katarzyna Kapelko‐Słowik et al. · Endocrine Research · 2012 · 42 citations